These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28231541)

  • 21. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
    He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
    Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
    Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
    J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and clinical significance of miR-139-5p in non-small cell lung cancer.
    Yong-Hao Y; Xian-Guo W; Ming X; Jin-Ping Z
    J Int Med Res; 2019 Feb; 47(2):867-874. PubMed ID: 30614351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN.
    Zhu DY; Li XN; Qi Y; Liu DL; Yang Y; Zhao J; Zhang CY; Wu K; Zhao S
    Biomed Pharmacother; 2016 Jul; 81():79-85. PubMed ID: 27261580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.
    Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C
    Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6.
    Sun C; Li S; Yang C; Xi Y; Wang L; Zhang F; Li D
    Biochem Biophys Res Commun; 2016 Feb; 471(1):82-8. PubMed ID: 26845350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD.
    Zhang Y; Xu X; Zhang M; Wang X; Bai X; Li H; Kan L; Zhou Y; Niu H; He P
    BMC Cancer; 2016 May; 16():315. PubMed ID: 27184257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.
    Liu L; Qu W; Zhong Z
    Int J Clin Exp Pathol; 2015; 8(5):5609-13. PubMed ID: 26191272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum level of microRNA-147 as diagnostic biomarker in human non-small cell lung cancer.
    Chu G; Zhang J; Chen X
    J Drug Target; 2016 Aug; 24(7):613-7. PubMed ID: 26581116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
    Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
    Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer.
    Tang R; Liang L; Luo D; Feng Z; Huang Q; He R; Gan T; Yang L; Chen G
    Med Sci Monit; 2015 Aug; 21():2514-20. PubMed ID: 26305739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of miR-4286 is an unfavorable prognostic marker in individuals with non-small cell lung cancer.
    An X; Ge J; Guo H; Mi H; Zhou J; Liu Y; Weiyue ; Wu Z
    J Cell Biochem; 2019 Oct; 120(10):17573-17583. PubMed ID: 31111550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of microRNA-124 is correlated with tumor metastasis and poor prognosis in patients with lung cancer.
    Zhang Y; Li H; Han J; Zhang Y
    Int J Clin Exp Pathol; 2015; 8(2):1967-72. PubMed ID: 25973090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations of deregulation of mir-365 and its target mRNA TTF-1 and survival in patients with NSCLC.
    Sun R; Liu Z; Ma G; Lv W; Zhao X; Lei G; Xu C
    Int J Clin Exp Pathol; 2015; 8(3):2392-9. PubMed ID: 26045746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-212 functions as a tumor-suppressor in human non-small cell lung cancer by targeting SOX4.
    Tang T; Huan L; Zhang S; Zhou H; Gu L; Chen X; Zhang L
    Oncol Rep; 2017 Oct; 38(4):2243-2250. PubMed ID: 28791372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miRNA-204 suppresses human non-small cell lung cancer by targeting ATF2.
    Zhang S; Gao L; Thakur A; Shi P; Liu F; Feng J; Wang T; Liang Y; Liu JJ; Chen M; Ren H
    Tumour Biol; 2016 Aug; 37(8):11177-86. PubMed ID: 26935060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-367 promotes the proliferation and invasion of non-small cell lung cancer via targeting FBXW7.
    Xu J; Wu W; Wang J; Huang C; Wen W; Zhao F; Xu X; Pan X; Wang W; Zhu Q; Chen L
    Oncol Rep; 2017 Feb; 37(2):1052-1058. PubMed ID: 28000899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Jumonji domain containing 2A predicts prognosis and regulates cell growth in lung cancer depending on miR-150.
    Xu W; Jiang K; Shen M; Chen Y; Huang HY
    Oncol Rep; 2016 Jan; 35(1):352-8. PubMed ID: 26498874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-498 is downregulated in non-small cell lung cancer and correlates with tumor progression.
    Wang M; Zhang Q; Wang J; Zhai Y
    J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C107-11. PubMed ID: 26323905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42.
    Yang T; Chen T; Li Y; Gao L; Zhang S; Wang T; Chen M
    Tumour Biol; 2015 Mar; 36(3):1903-11. PubMed ID: 25432132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.